All 23 cases were B-lymphoma. The 5-year survival rates of 22 patients were 65.9%, unfavorable variables for survival rate were higher serum LDH, high-risk IPI (P=0.02, P=0.01).

• 23骨非霍奇金淋巴瘤均为B细胞淋巴瘤,其中22例患者的5年生存率为65·9%25,血清LDH升高、国际预后指数高危类对预后不利(两者P值分别为0·02和0·01)。